The New York State Department of Health has issued a clinical laboratory permit for Natera, of San Carlos, Calif, enabling the company to make its portfolio of preconception and prenatal tests available to expecting parents in New York State.
Read MoreMolecular diagnostics company Biodesix announced that it has closed $8.4 million in Series E financing. The capital will help develop the company’s mass-spec technology platform and market the company’s first test, VeriStat, to guide NSCLC therapy.
Read More
Researchers have developed a test that will help pathologists clearly distinguish early liver cancer cells from nearly identical normal liver cells by giving them a distinctive red-brown hue.
Read More
Technologies go to the next level in diagnosing hospital-acquired infections
Read More
Scouting for new instrumentation, decision-support software, equipment, or diagnostic tests? It’s all in here.
Read More